{"prompt": "['2016N293064_0', 'CONFIDENTIAL', '2018N394263_00', '205864', 'Table 3', 'Assumptions used for the Simulations', 'Treatment Effect Assumptions', 'Variability Assumptions', 'Sample Size', '(\u00d4FEV1, \u00d4SGRQ)', '(OFEV1, OSGRQ)', 'Null', '(0,0)', '(25,10)', 'N=(50,100,150,200)', 'Alternate 1', '(5,-1)', '(25,10)', 'N=(50,100,150,200)', 'Alternate 2', '(5,0)', '(25,10)', 'N=(50,100,150,200)', 'Alternate 3', '(0,-1)', '(25,10)', 'N={50,100,150,200}', 'Data from a bivariate normal distribution were simulated under the four different', 'treatment effect assumptions for samples sizes of 50, 100, 150, and 200. The samples', 'from the posterior probability distribution from the MCMC approximation were divided', 'into four regions based on OFEVI and \u00f4SGRQ treatment effect cut-off values; SFEV1>0 and', '\u00d4SGRQ <0, SFEV1>0 and \u00d4SGRQ>0, SFEVI<0 and SSGRQ0, and SFEVI<0 and SSGRQ>0 Based', 'on a 70% threshold, the proportion of the 1000 simulations meeting the requirement', '& SSGRQ50) > 70% were considered a success based on the joint definition', '[Figure 2, Table 4]. & SSGRQ<0) < 70%, success could further be defined', 'based on each endpoint independently where P(OFEVI > 0) > 80% or P(6SGRQ 0) > 80%.', 'Figure 2', 'Total Probability of Success', '90', 'Alt 1: (5,-1)', '80', 'Alt 2: (5,0)', 'Alt 3: (0,-1)', 'Null: (0,0)', '02', '60', '50', 'of', '30', '50', '100', '150', '200', 'Sample Size', 'Table 4', 'Total Probability of Success (Figure 2)', 'N=50', 'N=100', 'N=150', 'N=200', '(5,-1)', '57.4', '68.5', '75.1', '81.4', '(5,0)', '52.5', '62.6', '67.8', '74.5', '(0,-1)', '42.6', '46.2', '48.9', '53.0', '(0,0)', '34.9', '33.9', '33.3', '31.5', '46']['2016N293064_0', 'CONFIDENTIAL', '2018N394263_00', '205864', 'Figure 3', 'Half Width of the 95% Confidence Interval of OFEV1 Point Estimate', 'DL', '13.8', '2L', '00', '9.7', '8.0', '8', '6.9', '6', '50', '100', '150', '200', 'Sample Size', 'Figure 4', 'Half Width of the 95% Confidence Interval of 5SGRQ Point Estimate', '6', '5.5', '5', '&', '3,9', 'm', '3.2', '2.7', '2', '50', '100', '150', '200', 'Sample Size', 'Based on the simulations, under the assumption of an expected treatment difference of', '(5,-1) which is the most probable scenario, the marginal increase for the total probability', 'of success is greatest when increasing the sample size from 50 to 100 (Figure 2). The half', 'widths of the 95% CI of the point estimate of the marginal treatment differences for FEV1', '(Figure 3) and SGRQ (Figure 4) have the greatest reduction from a sample size of 50 to', '100. A sample size of 100 will allow for an adequate level of confidence in the study', 'success while also considering the precision of the treatment effect differences.', '47']\n\n###\n\n", "completion": "END"}